RU2002105375A - APPLICATION OF GABAB RECEPTOR AGONISTS AND THEIR PHARMACEUTICALLY ACCEPTABLE DERIVATIVES FOR SUPPORTING THERAPY OF NICOTINE-DEPENDENT PATIENTS - Google Patents
APPLICATION OF GABAB RECEPTOR AGONISTS AND THEIR PHARMACEUTICALLY ACCEPTABLE DERIVATIVES FOR SUPPORTING THERAPY OF NICOTINE-DEPENDENT PATIENTSInfo
- Publication number
- RU2002105375A RU2002105375A RU2002105375/14A RU2002105375A RU2002105375A RU 2002105375 A RU2002105375 A RU 2002105375A RU 2002105375/14 A RU2002105375/14 A RU 2002105375/14A RU 2002105375 A RU2002105375 A RU 2002105375A RU 2002105375 A RU2002105375 A RU 2002105375A
- Authority
- RU
- Russia
- Prior art keywords
- use according
- gaba
- transdermal
- nicotine
- baclofen
- Prior art date
Links
- 239000000018 receptor agonist Substances 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 239000003185 4 aminobutyric acid B receptor stimulating agent Substances 0.000 claims 3
- KPYSYYIEGFHWSV-UHFFFAOYSA-N Baclofen Chemical compound OC(=O)CC(CN)C1=CC=C(Cl)C=C1 KPYSYYIEGFHWSV-UHFFFAOYSA-N 0.000 claims 3
- 229960000794 Baclofen Drugs 0.000 claims 2
- 150000002148 esters Chemical class 0.000 claims 2
- 150000002170 ethers Chemical class 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- 239000003826 tablet Substances 0.000 claims 2
- KPYSYYIEGFHWSV-QMMMGPOBSA-N (3R)-4-amino-3-(4-chlorophenyl)butanoic acid Chemical compound OC(=O)C[C@@H](CN)C1=CC=C(Cl)C=C1 KPYSYYIEGFHWSV-QMMMGPOBSA-N 0.000 claims 1
- MQIWYGZSHIXQIU-UHFFFAOYSA-O 3-phosphopropylazanium Chemical compound NCCC[P+](O)=O MQIWYGZSHIXQIU-UHFFFAOYSA-O 0.000 claims 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N GABA Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims 1
- SNICXCGAKADSCV-JTQLQIEISA-N Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims 1
- 229960002715 Nicotine Drugs 0.000 claims 1
- 206010057852 Nicotine dependence Diseases 0.000 claims 1
- NHVRIDDXGZPJTJ-UHFFFAOYSA-N SKF-97,541 Chemical compound CP(O)(=O)CCCN NHVRIDDXGZPJTJ-UHFFFAOYSA-N 0.000 claims 1
- 239000000556 agonist Substances 0.000 claims 1
- 229960003692 aminobutyric acid Drugs 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 230000000875 corresponding Effects 0.000 claims 1
- 235000019788 craving Nutrition 0.000 claims 1
- 230000001419 dependent Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- 239000012458 free base Substances 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000011159 matrix material Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 229930015196 nicotine Natural products 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 230000000391 smoking Effects 0.000 claims 1
- 239000007939 sustained release tablet Substances 0.000 claims 1
- 230000001225 therapeutic Effects 0.000 claims 1
Claims (9)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT1999MI001715A IT1313585B1 (en) | 1999-07-30 | 1999-07-30 | USE OF GABAB RECEPTOR AGONISTS FOR THE MAINTENANCE THERAPY OF NICOTINE ABSTINENCE IN NICOTINO-EMPLOYEES. |
ITM199A001715 | 1999-07-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2002105375A true RU2002105375A (en) | 2003-11-10 |
RU2262352C2 RU2262352C2 (en) | 2005-10-20 |
Family
ID=11383467
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2002105375/15A RU2262352C2 (en) | 1999-07-30 | 2000-06-30 | Applying agonists of gamma-aminobutyric acid receptors of b-type and their pharmaceutically acceptable derivatives in treatment of nicotine dependence |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1202727B1 (en) |
CN (1) | CN1176650C (en) |
AT (1) | ATE285763T1 (en) |
AU (1) | AU6153400A (en) |
CA (1) | CA2379752C (en) |
DE (1) | DE60017147T2 (en) |
DK (1) | DK1202727T3 (en) |
ES (1) | ES2235913T3 (en) |
HK (1) | HK1046849B (en) |
IL (2) | IL147876A0 (en) |
IT (1) | IT1313585B1 (en) |
PL (1) | PL196334B1 (en) |
PT (1) | PT1202727E (en) |
RU (1) | RU2262352C2 (en) |
SI (1) | SI1202727T1 (en) |
WO (1) | WO2001008675A1 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1660440E (en) | 2003-08-20 | 2012-05-15 | Xenoport Inc | Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
EP2354120A1 (en) | 2003-08-20 | 2011-08-10 | XenoPort, Inc. | Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof |
US7494985B2 (en) | 2004-11-03 | 2009-02-24 | Xenoport, Inc. | Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use |
US7566738B2 (en) | 2004-11-03 | 2009-07-28 | Xenoport, Inc. | Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use |
US7585996B2 (en) | 2006-09-15 | 2009-09-08 | Xenoport, Inc. | Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
JP4498407B2 (en) | 2006-12-22 | 2010-07-07 | キヤノン株式会社 | Process cartridge, electrophotographic image forming apparatus, and electrophotographic photosensitive drum unit |
WO2009094577A2 (en) | 2008-01-25 | 2009-07-30 | Xenoport, Inc. | Mesophasic forms of (3s)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use |
TWI380812B (en) | 2008-01-25 | 2013-01-01 | Xenoport Inc | Crystalline form of a (3s)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use |
EP2250148B1 (en) | 2008-01-25 | 2016-08-17 | XenoPort, Inc. | Crystalline form of calcium-salts of (3s)-aminomethyl-5-methyl-hexanoic acids and methods of use |
US7989641B2 (en) | 2008-08-07 | 2011-08-02 | Xenoport, Inc. | Methods of synthesizing N-hydroxysuccinimidyl carbonates |
US8299291B2 (en) | 2008-08-07 | 2012-10-30 | Xenoport, Inc. | Methods of synthesizing 1-(acyloxy)-alkyl carbamate prodrugs |
AU2010221270B2 (en) | 2009-03-03 | 2014-02-27 | Xenoport, Inc. | Sustained release oral dosage forms of an R-baclofen prodrug |
JP2012524065A (en) | 2009-04-17 | 2012-10-11 | ゼノポート,インコーポレーテッド | Γ-aminobutyric acid derivatives as GABAB receptor ligands |
WO2011081558A1 (en) * | 2009-08-21 | 2011-07-07 | Komissarov Jury Vladimirovich | Smoking device for giving up tobacco smoking |
WO2013023155A1 (en) | 2011-08-11 | 2013-02-14 | Xenoport, Inc. | Anhydrous and hemihydrate crystalline forms of an (r)-baclofen prodrug, methods of synthesis and methods of use |
JP2021521103A (en) * | 2018-04-06 | 2021-08-26 | オービッド・セラピューティクス・インコーポレイテッドOvid Therapeutics Inc. | Use of gaboxadol in the treatment of substance use disorders |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4126684A (en) * | 1976-02-11 | 1978-11-21 | Ciba-Geigy Corporation | 4-amino-3-p-halophenylbutyric acids and their derivatives used in the control of narcotic abuse |
US5073539A (en) * | 1990-01-22 | 1991-12-17 | Ciba-Geigy Corporation | Transdermal administration of zwitterionic drugs |
US5760049A (en) * | 1997-02-21 | 1998-06-02 | Synapse Pharmaceuticals International, Inc. | Method for controlling tobacco use and alleviating withdrawal symptoms due to cessation of tobacco use |
US6541520B1 (en) * | 1998-08-05 | 2003-04-01 | Brookhaven Science Associates | Treatment of addiction and addiction-related behavior |
-
1999
- 1999-07-30 IT IT1999MI001715A patent/IT1313585B1/en active
-
2000
- 2000-06-30 CN CNB00811031XA patent/CN1176650C/en not_active Expired - Lifetime
- 2000-06-30 DK DK00947901T patent/DK1202727T3/en active
- 2000-06-30 WO PCT/EP2000/006120 patent/WO2001008675A1/en active IP Right Grant
- 2000-06-30 DE DE60017147T patent/DE60017147T2/en not_active Expired - Lifetime
- 2000-06-30 AU AU61534/00A patent/AU6153400A/en not_active Abandoned
- 2000-06-30 IL IL14787600A patent/IL147876A0/en active IP Right Grant
- 2000-06-30 RU RU2002105375/15A patent/RU2262352C2/en active
- 2000-06-30 PT PT00947901T patent/PT1202727E/en unknown
- 2000-06-30 AT AT00947901T patent/ATE285763T1/en active
- 2000-06-30 CA CA002379752A patent/CA2379752C/en not_active Expired - Fee Related
- 2000-06-30 EP EP00947901A patent/EP1202727B1/en not_active Expired - Lifetime
- 2000-06-30 ES ES00947901T patent/ES2235913T3/en not_active Expired - Lifetime
- 2000-06-30 PL PL353373A patent/PL196334B1/en unknown
- 2000-06-30 SI SI200030632T patent/SI1202727T1/xx unknown
-
2002
- 2002-01-28 IL IL147876A patent/IL147876A/en unknown
- 2002-10-31 HK HK02107911.9A patent/HK1046849B/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2002105375A (en) | APPLICATION OF GABAB RECEPTOR AGONISTS AND THEIR PHARMACEUTICALLY ACCEPTABLE DERIVATIVES FOR SUPPORTING THERAPY OF NICOTINE-DEPENDENT PATIENTS | |
AU2018240540B2 (en) | Novel compositions and methods | |
RU2404750C2 (en) | Composition containing base or coat for moderated release and antagonist of nmda receptor, method for introduction of such nmda antagonist to individual | |
ES2227814T3 (en) | DOSAGE FORMS THAT INCLUDE SEPARATE PORTIONS OF ENANTIOMEROS R AND S. | |
JP2005512995A5 (en) | ||
JP2005515966A5 (en) | ||
JP2004534057A5 (en) | ||
KR20060077812A (en) | Controlled release complex formulation for oral administration of medicine for diabetes and method for the preparation thereof | |
RU2003116058A (en) | COMPOSITIONS OF A HYDROCODON WITH CONTROLLED RELEASE | |
WO2003004032A1 (en) | Oral administration of 6-hydroxy-oxymorphone for use as an analgesic | |
NZ231923A (en) | Adhesive tablet comprising baclofen in a hydrophilic core with a hydrophobic coating | |
WO1999002158A1 (en) | Stable medicinal compositions containing 4,5-epoxymorphinane derivatives | |
EP1275381A4 (en) | Time-release coated solid compositions for oral administration | |
AU2002316582A1 (en) | Oral administration of 6-hydroxy-oxymorphone for use as an analgesic | |
US20210308040A1 (en) | Ketamine oral transmucosal delivery system | |
KR102479497B1 (en) | Sustained release pharmaceutical formulation of varenicline and preparation method thereof | |
JPS63243024A (en) | Administrative medicine of pseudoephedorin and brompheniramine | |
EP3785698B1 (en) | Edaravone pharmaceutical composition | |
JP2023506545A (en) | Transmucosal therapeutic system containing agomelatine | |
CZ289395A3 (en) | Transdermic therapeutic system for administration of serotonin agonists | |
JP2005537221A (en) | Controlled release formulation of tramadol | |
JPH08295637A (en) | Local administrative agent for oral cavity | |
JP2001508769A (en) | Pharmaceutical composition comprising alendronate and an agent for promoting gastric emptying | |
KR101175816B1 (en) | Sustained release tablet for oral use | |
WO2016137266A2 (en) | Pharmaceutical composition containing eperisone and pelubiprofen |